Exact Sciences
EXAS
#1638
Rank
ยฃ8.36 B
Marketcap
ยฃ45.21
Share price
0.04%
Change (1 day)
-9.86%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Earnings for Exact Sciences (EXAS)

Earnings in 2024 (TTM): -ยฃ0.16 Billion

According to Exact Sciences's latest financial reports the company's current earnings are ยฃ2.69 Billion. In 2023 the company made an earning of -ยฃ0.16 Billion, an increase over its 2022 earnings that were of -ยฃ0.5 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Exact Sciences from 2001 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -ยฃ0.16 Billion-1.93%
2023 -ยฃ0.16 Billion-69.28%
2022 -ยฃ0.5 Billion-25.55%
2021 -ยฃ0.67 Billion1.68%
2020 -ยฃ0.66 Billion271.17%
2019 -ยฃ0.18 Billion58.99%
2018 -ยฃ0.12 Billion20.89%
2017 -ยฃ92.25 Million-30.95%
2016 -ยฃ0.14 Billion5.09%
2015 -ยฃ0.13 Billion57.24%
2014 -ยฃ80.85 Million116.53%
2013 -ยฃ37.34 Million
2011 -ยฃ23.25 Million143.73%
2010 -ยฃ9.54 Million27.85%
2009 -ยฃ7.47 Million0.27%
2008 -ยฃ7.45 Million-20.95%
2007 -ยฃ9.42 Million-13.53%
2006 -ยฃ10.89 Million-10.07%
2005 -ยฃ12.11 Million-21.81%
2004 -ยฃ15.49 Million-33.44%
2003 -ยฃ23.26 Million-6.51%
2002 -ยฃ24.88 Million17.95%
2001 -ยฃ21.1 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-ยฃ91.63 Million-40.71%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ53.13 M-134.38%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ6.59 Million-95.74%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ28.21 Million-81.75%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ5.97 B-3,966.20%๐Ÿ‡ซ๐Ÿ‡ท France